Hormone Receptor Status Influences the Locoregional Benefit of Trastuzumab in Patients with Non-metastatic Breast Cancer

BACKGROUND: Previous studies have shown that hormone receptor (HR) and HER2 status influence the outcome of locoregional treatments. However, the interrelationship of these factors with trastuzumab is unclear. We sought to determine the role of HR and HER2 status on the locoregional benefit of trast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Michelle M., Dawood, Shaheenah, Allen, Pamela, Sahin, Aysegul A., Woodward, Wendy A., Smith, Benjamin D., Strom, Eric A., Hunt, Kelly K., Meric-Bernstam, Funda, Gonzalez-Angulo, Ana Maria, Buchholz, Thomas A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3888990/
https://ncbi.nlm.nih.gov/pubmed/22511276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27502
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados